NEW YORK (TheStreet) -- CHANGE IN RATINGS
Abercrombie & Fitch (ANF) was downgraded to hold at TheStreet Ratings.
Cubist (CBST) was upgraded at Mizuho to buy from neutral. $77 price target. Acquisitions should help drive near-term growth, Mizuho said.
C&J Energy (CJES) was downgraded at Cowen to market perform from outperform. $22.30 price target. Fracturing services market continues to suffer from chronic oversupply, Cowen said.Ellington Financial (EFC) was upgraded to hold at TheStreet Ratings. (EOG) was upgraded at Credit Suisse to outperform from neutral. $175 price target. Estimates were also increased, given higher oil production forecasts, Credit Suisse said. Iberiabank (IBKC) was downgraded at Oppenheimer to perform from outperform. Company is seeing pressure in mortgage banking, Oppenheimer said. K12 (LRN) was downgraded at Robert Baird to neutral from outperform. $25 price target. Company slashed its guidance, Baird said. K12 was downgraded at BMO Capital to market perform from outperform. $22 price target. Company is seeing lower enrollment growth, BMO Capital said. Masco (MAS) was upgraded at J.P. Morgan to overweight from neutral. $21 price target. Valuation is reasonable against unaggressive 2015 estimates, J.P. Morgan said. (MRK) was initiated with a neutral rating at Credit Suisse. $49 price target. Core franchises are facing growth challenges, Credit Suisse said. Owens Corning (OC) was upgraded at J.P. Morgan to overweight from neutral. $45 price target. More constructive view on repair/remodel focused building product names, J.P. Morgan said. Pfizer (PFE) was initiated with an outperform rating at Credit Suisse. $34 price target. Restructuring story will likely continue to evolve, Credit Suisse said. Patterson-UTI (PTEN) was downgraded at Cowen to perform from outperform. $24 price target. Pressure pumping prices will likely show no improvement, Cowen said. Viropharma (VPHM) was downgraded at Mizuho to neutral from buy. Valuation call, based on a $39 price target, Mizuho said.
Stock Comments / EPS ChangesHain Celestial (HAIN) estimates were cut at Jefferies through 2013. Guidance below consensus at analyst day, Jefferies said. Buy rating and $91 price target.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV